Ads
related to: legal performance-enhancing drugs
Search results
Earnings call: DLH Holdings disclosed a revenue of $101 million
Investing.com· 7 days agoThe company has successfully increased its backlog to $736 million and secured significant...
JD Supra: FDA AI & Medical Products Paper advocates for a tailored risk-based regulatory framework
JD Supra· 5 days agoPrevious agency publications include discussion papers on AI in drug development and advanced manufacturing, which we discussed online here.
Q2 2024 DLH Holdings Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 days agoOur EBITDA for the quarter was in line with last year, even given approximately $1 million in aggregate of Seamap procurement related legal costs and strategic positioning ...
DLH Holdings Corp. (NASDAQ:DLHC) Q2 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoDLH Holdings Corp. (NASDAQ:DLHC) Q2 2024 Earnings Call Transcript May 3, 2024 DLH Holdings Corp....
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
Guru Focus· 6 days agoOn May 3, 2024, AbbVie Inc (ABBV, Financial), a global biopharmaceutical powerhouse, filed its 10-Q report, revealing a comprehensive snapshot of its financial health and strategic positioning ...
Invitae Receives Court Approval for Sale to Labcorp
Colorado Springs Gazette· 2 days agoLabcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and Invitae (OTC:NVTAQ), a leading medical genetics company, announced today that the United States Bankruptcy ...